ArticleMolecular therapy : the journal of the American Society of Gene Therapy2014

The strength of the T cell response against a surrogate tumor antigen induced by oncolytic VSV therapy does not correlate with tumor control.

Valérie Janelle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.